The Future of Clinical Trials
Transforming healthcare with patient-driven, data-powered clinical trials for a healthier future.
Now more than ever, the clinical trials sector is capable of advancing medicine and contributing to a positive future for the human race. Multiple forces are elevating and amplifying the importance of clinical trials around the world. The cost and value of medicine are becoming increasingly critical as the global life sciences industry seeks to innovate high-quality drugs faster and cheaper.
There is now a vast array of data at our fingertips, enough to enable truly personalized medicine on a previously unachievable scale. In turn, this is facilitating new cell and gene therapies that target smaller population groups. And all these changes are empowering patients who, for decades, have been asking for a voice and for greater autonomy in the development of their own treatments.
Downloads
The Future of Clinical Trials Webinar
In this new era of clinical trials, compliance continues to be an overarching imperative along with the need for sustainability. More and more clinical trials are leveraging virtual health tools and mobile technology, and robust yet agile logistics solutions and supply chain processes are now essential to the success of each trial. Watch our webinar to learn more!
Speakers
Thomas Ellmann
VP, Head of Clinical Trials Logistics, DHL Customer Solutions & Innovation
Since January 2019 Thomas Ellmann has been responsible for the X-BU development of Clinical Trials Logistics. He coordinates the Solutions and Services development across the different Divisions in DHL and serves as a member of the Global Life Sciences Senior Management Sector Team.
In past months he supported DHL Covid-19 Vaccines distribution as a co-author of the White Papers on “Pandemic Resilience” and is leading the business development efforts in the Global Task Force to support distribution readiness for global vaccines manufacturers and Governments and NGOs.
Markus Ofenloch
Head Global Clinical Distribution, Roche
Markus Ofenlock is Head Global Clinical Distribution at Roche. Based in Basel, Switzerland, Markus’ career within the organization has included not only clinical distribution but also supply chain management.
Rebeca Gonzalez Vincedo
Director of Decentralized Clinical Trials, EMOVIS
Rebeca believes that patients must be at the center of clinical trials. For years, she has provided solutions with decentralized elements to sponsors and CROs. As Director of emovis Homecare Visits, she and her team have supported over 50 clinical trials with homecare visits, getting to see its benefits but also understanding the challenges some elements can bring for different stakeholders.
Currently, she is working on combining the benefits of digital innovation with emovis' expertise and experience to bring trials even closer to patients and provide decentralized clinical trial solutions.
Full List of Speakers
Full list of speakers - Thomas Ellmann (VP, Head of Clinical Trials Logistics), Markus Ofenloch (Head Global Clinical Distribution), Rebeca Gonzalez Vincedo (Director of Decentralized Clinical Trials), Peter Turner (Head of Supply Logistics, Comparators and Collaborations), Dr. Matthias Roos (Pharma Sector Lead), Tatjana Vorobjova ( Associate Director, Network Strategy, Clinical Supply Chain). To find more information on the speakers list, click here.
Explore Life Sciences and Healthcare Logistics at DHL
Explore our solutions and customer case studies, as well as deep dives on pharmaceuticals, medical devices, clinical trials, consumer healthcare and aid and relief